OpenIcon research & analysis

Information Technology

Stocks Covered
Finance &

Foreseeing value & Offering insight

Seeking Alpha articles by William P. Meyers

Recent and Popular:

Syndax Pharmaceuticals Undervalued On Coming Data Readouts [February 15, 2018 @ Seeking Alpha]

Reata Pharmaceuticals A Buy On Bardoxolene Data [February 14, 2018 @ Seeking Alpha]

Celldex Value Depends on Coming Data [February 8, 2018 @ Seeking Alpha]

ImmunoGen Price Run-Up Driven by Potential Trial Data [Feb. 6, 2018 at SA]

Endocyte Has a Strong Phase 3 Ready Asset
[January 31, 2018 at Seeking Alpha]

Buy Agios [January 10, 2018 at Seeking Alpha]

William Meyers changes 2018 stocks covered

BiTE Amgen for Long-term Returns [December 16, 2017 @ Seeking Alpha]

Gilead Sciences Going Down When It Should Go Up [Seeking Alpha, 12/8/2017]

Celgene is Oversold [Seeking Alpha, 11/30/2017]

Incyte Q3 Result Could Be An Upward Inflection Point [Seeking Alpha, 11/2/2017]

Applied Materials Still A Buy After 59% YTD Gain [October 6, 2017 @ Seeking Alpha]

Evaluating AMD's Server Market Potential [July 7, 2017 at Seeking Alpha]

GlycoMimetics Remains Undervalued After Leukemia Data Release [June 14, 2017 at Seeking Alpha]

Immune Checkpoint Inhibitors

Biotechnology stocks covered

Biotech Research Help page

The Accounting System: The New Money Cloud

Links to Quarterly Results Notes

Dissecting the Bull blog

Finance and Economics Commentary


(experimental): Random Stock Picker


Machine Understanding (AI) [discontinued]